Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization
We congratulate Cheng and associates on their article “Short-term topical bevacizumab in the treatment of stable corneal neovascularization.” A couple of concerns were raised in our minds after careful reading the manuscript.